A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

Clinical trial NCT07204964 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07204964
Sponsor: GlaxoSmithKline
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2025-10-07
Primary completion: 2026-07-31
Enrollment: 971

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.